Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sophia Genetics
(NASDAQ:SOPH)
Intraday
$5.21
0.15
[2.96%]
After-Hours
$5.21
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$5.21
0.15
[2.96%]
At close: Mar 28
$5.21
0
[0.00%]
After Hours: 9:25AM EDT
Get Report
Watch
Q1 2024 Earnings in 12 days from now on Tue May 7th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Sophia Genetics Stock (NASDAQ:SOPH)
Sophia Genetics Stock (NASDAQ: SOPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
SOPHiA GENETICS Announced That Unilabs Is Live On The SOPHiA DDM Platform To Test For HRD-Status In Solid Tumors And Provide Expedited Analysis Across Its Network In Switzerland
Benzinga Newsdesk
-
Apr 17, 2024, 6:08AM
Thursday, April 04, 2024
SOPHiA GENETICS And Strand Life Sciences Enter New Strategic Partnership, To Advance The Use Of Precision Medicine
Benzinga Newsdesk
-
Apr 4, 2024, 2:04AM
Wednesday, March 20, 2024
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada
Benzinga Newsdesk
-
Mar 20, 2024, 10:02AM
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Mar 18, 2024, 5:33PM
Friday, March 15, 2024
SOPHiA Genetics And The French Kidney Cancer Research Network (UroCCR) Publish Results From Multiyear Collaboration On A Study Using A Multimodal Algorithm To Predict Post-operative Outcomes For Those Facing Renal Cell Carcinoma
Benzinga Newsdesk
-
Mar 15, 2024, 6:08AM
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 6, 2024, 1:54PM
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8
Benzinga Newsdesk
-
Mar 6, 2024, 1:04PM
RBC Capital Reiterates Outperform on Sophia Genetics, Maintains $8 Price Target
Benzinga Newsdesk
-
Mar 6, 2024, 10:21AM
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 6, 2024, 8:14AM
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Mar 6, 2024, 5:00AM
Tuesday, March 05, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 5, 2024, 4:31PM
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 5, 2024, 1:11PM
Sophia Genetics shares are trading lower after the company reported worse than expected Q4 earnings and issued 2024 guidance.
Benzinga Newsdesk
-
Mar 5, 2024, 8:44AM
SOPHiA GENETICS Forecasts 2024 Revenue Of $78M-$81M, Up 25%-30% YoY Compared To Consensus Of $82.11M
Benzinga Newsdesk
-
Mar 5, 2024, 6:57AM
Sophia Genetics Q4 GAAP EPS $(0.37) Misses $(0.27) Estimate, Sales $17.05M Miss $17.33M Estimate
Benzinga Newsdesk
-
Mar 5, 2024, 6:55AM
Earnings Scheduled For March 5, 2024
Benzinga Insights
-
Mar 5, 2024, 5:00AM
Monday, March 04, 2024
Preview: Sophia Genetics's Earnings
Benzinga Insights
-
Mar 4, 2024, 12:01PM
Wednesday, February 07, 2024
SOPHiA GENETICS Has Expanded An Existing Program In Spain To Increase Access To Local Testing For Homologous Recombination Deficiency Throughout The Country. The Expansion Of The Program Is Supported By AstraZeneca Spain
Benzinga Newsdesk
-
Feb 7, 2024, 6:53AM
Thursday, January 25, 2024
SOPHiA GENETICS Announced That Bioma4me, A Brazil-Based Company Focused On Genetic Sequencing To Drive Precision Medicine To The Brazilian Population, Is Now Live On The SOPHiA DDM Platform
Benzinga Newsdesk
-
Jan 25, 2024, 10:52AM
Monday, January 22, 2024
Top 5 Health Care Stocks That May Crash This Month
Avi Kapoor
-
Jan 22, 2024, 7:34AM
Thursday, January 18, 2024
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio With SOPHiA DDM
Benzinga Newsdesk
-
Jan 18, 2024, 3:03PM
Friday, January 12, 2024
RBC Capital Reiterates Outperform on Sophia Genetics, Maintains $8 Price Target
Benzinga Newsdesk
-
Jan 12, 2024, 11:25AM
Monday, January 08, 2024
SOPHiA GENETICS Announce Collaboration With Exactis Innovation On Multimodal Data Analytics; Exactis To Join SOPHiA DDM Network And Leverage Platform To Access Data
Benzinga Newsdesk
-
Jan 8, 2024, 9:38AM
Thursday, December 07, 2023
SOPHiA GENETICS Announces Expanded Suite Of Liquid Biopsy Offerings
Benzinga Newsdesk
-
Dec 7, 2023, 9:06AM
Wednesday, November 29, 2023
RBC Capital Initiates Coverage On Sophia Genetics with Outperform Rating, Announces Price Target of $8
Benzinga Newsdesk
-
Nov 29, 2023, 5:53AM
Tuesday, November 28, 2023
SOPHiA GENETICS Expands Relationship With Città della Salute e della Scienza di Torino
Benzinga Newsdesk
-
Nov 28, 2023, 7:14AM
Tuesday, November 07, 2023
SOPHiA GENETICS Reaffirms FY23 Full-Year Reported Revenue Growth At Or Above 30%; Full-Year Constant Currency Revenue Growth Excluding COVID-19-Related Revenue 30%-35%
Benzinga Newsdesk
-
Nov 7, 2023, 8:48AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Sophia Genetics Q3 2023 Gaap EPS $(0.21) Beats $(0.31) Estimate, Sales $16.30M Beat $15.63M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 6:33AM
Monday, November 06, 2023
Earnings Preview: Sophia Genetics
Benzinga Insights
-
Nov 6, 2023, 4:02PM
Wednesday, October 18, 2023
Sophia Genetics Collaborated With Memorial Sloan Kettering Cancer Center And Astrazeneca To Advance Health Equity On A Global Scale By Providing Inclusive Access To Comprehensive Cancer Testing
Benzinga Newsdesk
-
Oct 18, 2023, 8:07AM
Friday, September 29, 2023
SOPHiA GENETICS Says Jerusalem-Based Shaare Zedek Medical Center Uses SOPHiA DDM Platform To Advance Research of Myeloid Disorders
Benzinga Newsdesk
-
Sep 29, 2023, 6:10AM
Tuesday, August 22, 2023
Sophia Genetics Announced The Expansion Of Its Relationship With Gustave Roussy, A Cancer Center In Europe To Provide Expedited Analysis And Insights Of Genomic Profiles
Benzinga Newsdesk
-
Aug 22, 2023, 6:06AM
Tuesday, August 08, 2023
Sophia Genetics Reaffirms FY23 Outlook: Revenue Growth At Or Above 30%, Operating Losses Below 2022 Levels
Benzinga Newsdesk
-
Aug 8, 2023, 8:44AM
Sophia Genetics Q2 EPS $(0.33) Misses $(0.29) Estimate, Sales $15.05M Miss $15.10M Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 7:13AM
Earnings Scheduled For August 8, 2023
Benzinga Insights
-
Aug 8, 2023, 4:48AM
Monday, August 07, 2023
A Preview Of Sophia Genetics's Earnings
Benzinga Insights
-
Aug 7, 2023, 4:02PM
Thursday, June 22, 2023
Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform
Benzinga Newsdesk
-
Jun 22, 2023, 6:02AM
Wednesday, May 10, 2023
Credit Suisse Maintains Neutral on Sophia Genetics, Raises Price Target to $5
Benzinga Newsdesk
-
May 10, 2023, 9:10AM
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $10
Benzinga Newsdesk
-
May 10, 2023, 8:14AM
Tuesday, May 09, 2023
Sophia Genetics Q1 Adj EPS $(0.26) Beats $(0.32) Estimate, Sales $14.00M Beat $13.89M Estimate
Benzinga Newsdesk
-
May 9, 2023, 6:56AM
Earnings Scheduled For May 9, 2023
Benzinga Insights
-
May 9, 2023, 6:03AM
Tuesday, April 04, 2023
SOPHiA GENETICS Announces Tel Aviv Sourasky Medical Center Will Use SOPHiA DDM
Benzinga Newsdesk
-
Apr 4, 2023, 9:04AM
Monday, March 20, 2023
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Mar 20, 2023, 2:18PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 20, 2023, 1:31PM
Tuesday, March 14, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 14, 2023, 5:33PM
SOPHiA GENETICS DDM Platform To Be Integrated With Agilent's SureSelect Cancer Comprehensive Genomic Profiling Assay Kit
Bill Haddad
-
Mar 14, 2023, 9:04AM
Wednesday, March 08, 2023
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $11
Benzinga Newsdesk
-
Mar 8, 2023, 7:33AM
Tuesday, March 07, 2023
Sophia Genetics Expects FY23 Revenue Growth To Be At Or Above 30%
Benzinga Newsdesk
-
Mar 7, 2023, 7:04AM
Sophia Genetics Q4 Adjusted EPS $(0.17) Beats $(0.36) Estimate, Sales $13.38M Beat $12.91M Estimate
Benzinga Newsdesk
-
Mar 7, 2023, 7:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch